Epicrispr Biotechnologies vs SonoThera
Epicrispr Biotechnologies vs SonoThera, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and SonoThera on 53/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 53/100
- agent readiness: 39/100 against 21/100
- domain rating: 40/100 against 25/100
SonoThera
- funding raised: $125M against $90.0M
At a glance
| Measure | Epicrispr Biotechnologies | SonoThera |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Developing ultrasound-mediated nonviral genetic medicines. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Healthcare, Gene Therapy, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2019 |
| Headquarters | South San Francisco, United States | San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | SonoThera |
|---|---|---|
| Employees | 51 | 54 |
| Total funding | $90.0M | $125M |
| Latest round | Series C | Series B |
| LinkedIn followers | 7,025 | 5,837 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | SonoThera |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 53/100 |
| Traction | 57/100 | 57/100 |
| Team | 40/100 | Not published |
| Search visibility | 20/100 | 33/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 25/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | SonoThera |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4, Jetpack Stats |
What users say
| Measure | Epicrispr Biotechnologies | SonoThera |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 1 thread |
“SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A.”r/Hemophilia
Epicrispr Biotechnologies vs SonoThera: common questions
Which is better, Epicrispr Biotechnologies or SonoThera?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and SonoThera compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 53/100), agent readiness (39/100 against 21/100), domain rating (40/100 against 25/100). SonoThera leads on funding raised ($125M against $90.0M).
What do real users say about Epicrispr Biotechnologies and SonoThera?
SonoThera: 1 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/Hemophilia.
Read the full Epicrispr Biotechnologies review and pricing or the SonoThera review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.